October 23, 2007

Pfizer posts 13 percent revenue increase

Pfizer's animal health division reported posted third-quarter 2007 revenues of US$636 million, a 13 percent jump in comparison to US$562 million in the same period last year.

For the first nine months of 2007, revenues increased 12 percent to US$1.9 billion compared to US$1.7 billion in the same period last year due to strong product performance of companion animal and international livestock businesses.

The acquisition of Embrex, a company that vaccinates chicks while inside their eggs and the favourable impact of foreign exchange also contributed to the increase.

Overall, Pfizer generated third-quarter 2007 revenues of US$12.0 billion, a 2 percent decline from the same period last year.